Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds

Advertising today archive

3102 PWToday Stories

Alira Health Acquires Clinical Assistance Programs

20 Feb 18

Alira Health, an international healthcare and life science advisory firm, announced that it has acquired Clinical Assistance Programs (CAP), a contract research organization providing a full range of clinical trial management and consulting services.

The purchase will strengthen Alira Health's scientific and clinical core. The combined organization will provide a full range of services across regulatory, clinical research and medical affairs. This expansion reinforces Alira Health's commitment to simplifying their clients' complex journey through the healthcare and life science product lifecycle. 

"CAP's expertise in clinical trial management is a perfect complement to our suite of services. This strategic acquisition enhances our ability to support our clients' drug and device clinical research programs," said Gabriele Brambilla, CEO of Alira Health. "With the addition of CAP's outstanding team, Alira Health continues its focus on advancing innovation in healthcare."

"This acquisition will provide CAP with access to additional scientific expertise, enhance our regulatory and therapeutic service offerings and expand our geographic reach.  CAP and Alira Health share collaborative, quality-driven cultures and a strategic vision.  Now we can provide to our healthcare clients a broader array of services with the same passion and quality for which we are known," said Harry Barnett, JD, Managing Partner of Clinical Assistance Programs.

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.